Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03025542. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
ClinicalTrials.gov study NCT00735787. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
ClinicalTrials.gov study NCT03721172. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03482011. IPD Sharing: YES. Countries: 9. Publications: 1.
The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03638258. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Registry of Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02786186. IPD Sharing: UNDECIDED. Countries: 8. Publications: 2.
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
ClinicalTrials.gov study NCT04271735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01899729. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
ClinicalTrials.gov study NCT01866163. IPD Sharing: NO. Countries: 1. Publications: 4.
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00663052. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00678210. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
ClinicalTrials.gov study NCT04720105. IPD Sharing: NO. Countries: 1. Publications: 6.
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03701763. IPD Sharing: YES. Countries: 10. Publications: 1.
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
ClinicalTrials.gov study NCT05272150. IPD Sharing: YES. Countries: 2. Publications: 3.
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
ClinicalTrials.gov study NCT04713592. IPD Sharing: YES. Countries: 4. Publications: 0.
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
ClinicalTrials.gov study NCT00924950. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05073315. IPD Sharing: YES. Countries: 6. Publications: 0.
Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02850965. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00115076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03392168. IPD Sharing: NO. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.